Post-pandemic Era-Global Cancer Vaccines Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026

Report ID: 254759 | Published Date: Jan 2025 | No. of Page: 119 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global Cancer Vaccines Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
    1.1 Product Details and Introduction
      1.1.1 Rophylactic Vaccines -Product Introduction and Major Manufacturers
      1.1.2 Therapeutic Vaccines -Product Introduction and Major Manufacturers
    1.2 Market Snapshot
      1.2.1 Major Companies Overview
      1.2.2 Market Concentration
      1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Cancer Vaccines Market Assessment, by Segmentation
    2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
    2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
    2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)
3 Regional Market Analysis
    3.1 China Cancer Vaccines Market
      3.1.1 Top Companies leading Cancer Vaccines Development in China (2015-2020)
      3.1.2 Sales Value of Major Company in China Market (2015-2020)
      3.1.3 China Cancer Vaccines Price (USD/Unit), by Type (2019-2020)
      3.1.4 Sales in China Market, by Type (2015-2026)
    3.2 EU Cancer Vaccines Market
      3.2.1 Top Companies leading Cancer Vaccines Development in EU (2015-2020)
      3.2.2 Sales Value of Major Company in EU Market (2015-2020)
      3.2.3 EU Cancer Vaccines Price (USD/Unit), by Type (2019-2020)
      3.2.4 Sales in EU Market, by Type (2015-2026)
    3.3 USA Cancer Vaccines Market
      3.3.1 Top Companies leading Cancer Vaccines Development in USA (2015-2020)
      3.3.2 Sales Value of Major Company in USA Market (2015-2020)
      3.3.3 USA Cancer Vaccines Price (USD/Unit), by Type (2019-2020)
      3.3.4 Sales in USA Market, by Type (2015-2026)
    3.4 Japan Cancer Vaccines Market
      3.4.1 Top Companies leading Cancer Vaccines Development in Japan (2015-2020)
      3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
      3.4.3 Japan Cancer Vaccines Price (USD/Unit), by Type (2019-2020)
      3.4.4 Sales in Japan Market, by Type (2015-2026)
    3.5 India Cancer Vaccines Market
      3.5.1 Top Companies leading Cancer Vaccines Development in India (2015-2020)
      3.5.2 Sales Value of Major Company in India Market (2015-2020)
      3.5.3 India Cancer Vaccines Price (USD/Unit), by Type (2019-2020)
      3.5.4 Sales in India Market, by Type (2015-2026)
    3.6 Southeast Asia Cancer Vaccines Market
      3.6.1 Top Companies leading Cancer Vaccines Development in Southeast Asia (2015-2020)
      3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
      3.6.3 Southeast Asia Cancer Vaccines Price (USD/Unit), by Type (2019-2020)
      3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
    3.7 South America Cancer Vaccines Market
      3.7.1 Top Companies leading Cancer Vaccines Development in South America (2015-2020)
      3.7.2 Sales Value of Major Company in South America Market (2015-2020)
      3.7.3 South America Cancer Vaccines Price (USD/Unit), by Type (2019-2020)
      3.7.4 Sales in South America Market, by Type (2015-2026)
4 Value Chain (Impact of COVID-19)
    4.1 Cancer Vaccines Value Chain Analysis
      4.1.1 Upstream
      4.1.2 Downstream
    4.2 COVID-19 Impact on Cancer Vaccines Industry
      4.2.1 Industrial Policy Issued Under the Epidemic Situation
    4.3 Cost-Under the Epidemic Situation
      4.3.1 Cost of Raw Material
    4.4 Channel Analysis
      4.4.1 Distribution Channel-Under the Epidemic Situation
      4.4.2 Distributors
5 Regional Market Forecast (2021-2026)
    5.1 Global Cancer Vaccines Sales and Growth Rate (2021-2026)
    5.2 Global Cancer Vaccines Sales Value and Growth Rate (2021-2026)

6 Cancer Vaccines Competitive Analysis
     6.1 Dendreon
        6.1.1 Dendreon Company Profiles
        6.1.2 Dendreon Product Introduction
        6.1.3 Dendreon Cancer Vaccines Production, Revenue (2015-2020)
        6.1.4 SWOT Analysis
     6.2 GlaxoSmithKline
        6.2.1 GlaxoSmithKline Company Profiles
        6.2.2 GlaxoSmithKline Product Introduction
        6.2.3 GlaxoSmithKline Cancer Vaccines Production, Revenue (2015-2020)
        6.2.4 SWOT Analysis
     6.3 Merck
        6.3.1 Merck Company Profiles
        6.3.2 Merck Product Introduction
        6.3.3 Merck Cancer Vaccines Production, Revenue (2015-2020)
        6.3.4 SWOT Analysis
     6.4 Sanofi
        6.4.1 Sanofi Company Profiles
        6.4.2 Sanofi Product Introduction
        6.4.3 Sanofi Cancer Vaccines Production, Revenue (2015-2020)
        6.4.4 SWOT Analysis
     6.5 Amgen
        6.5.1 Amgen Company Profiles
        6.5.2 Amgen Product Introduction
        6.5.3 Amgen Cancer Vaccines Production, Revenue (2015-2020)
        6.5.4 SWOT Analysis
     6.6 Biothera
        6.6.1 Biothera Company Profiles
        6.6.2 Biothera Product Introduction
        6.6.3 Biothera Cancer Vaccines Production, Revenue (2015-2020)
        6.6.4 SWOT Analysis
     6.7 Isa Pharmaceuticals
        6.7.1 Isa Pharmaceuticals Company Profiles
        6.7.2 Isa Pharmaceuticals Product Introduction
        6.7.3 Isa Pharmaceuticals Cancer Vaccines Production, Revenue (2015-2020)
        6.7.4 SWOT Analysis
     6.8 Bristol-Myers Squibb
        6.8.1 Bristol-Myers Squibb Company Profiles
        6.8.2 Bristol-Myers Squibb Product Introduction
        6.8.3 Bristol-Myers Squibb Cancer Vaccines Production, Revenue (2015-2020)
        6.8.4 SWOT Analysis
     6.9 Bavarian Nordic
        6.9.1 Bavarian Nordic Company Profiles
        6.9.2 Bavarian Nordic Product Introduction
        6.9.3 Bavarian Nordic Cancer Vaccines Production, Revenue (2015-2020)
        6.9.4 SWOT Analysis
     6.10 Antigen Express
        6.10.1 Antigen Express Company Profiles
        6.10.2 Antigen Express Product Introduction
        6.10.3 Antigen Express Cancer Vaccines Production, Revenue (2015-2020)
        6.10.4 SWOT Analysis
     6.11 Juvaris Biotherapeutics
     6.12 Provectus Biopharmaceuticals
     6.13 Aduro BioTech
     6.14 Galena Biopharma
     6.15 Northwest Biotherapeutics
     6.16 Oxford BioMedica
     6.17 Inovio Pharmaceuticals
     6.18 Vaxon Biotech
     6.19 Celldex Therapeutics
     6.20 Prima BioMed
7 Conclusion


List of Tables and Figures

    Figure Product Introduction
    Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
    Figure Global Cancer Vaccines Production Market Share of Top 5 Players
    Table CAGR of Major Market (2021-2026)
    Table CAGR in Terms of Production of Each Type (2015-2026)
    Table CAGR in Terms of Production of Each Application (2015-2026)
    Table Global Cancer Vaccines Sales (K Unit) by Type (2015-2026)
    Figure Global Cancer Vaccines Sales (K Unit) and Growth Rate (2015-2026)
    Figure Global Cancer Vaccines Sales Market Share (%) by Type (2019 -2020)
    Table Global Cancer Vaccines Sales Value (Million USD) by Type (2015-2026)
    Figure Global Cancer Vaccines Sales Value (Million USD) and Growth Rate (2015-2026)
    Figure Global Cancer Vaccines Sales Value Market Share (%) by Type (2019-2020)
    Table Global Cancer Vaccines Sales (K Unit) by Application (2015-2026)
    Table China Cancer Vaccines Sales (K Unit) of Major Company (2015-2020)
    Table China Cancer Vaccines Sales Market Share of Major Company (2015-2020)
    Table China Cancer Vaccines Sales Value (Million USD) of Major Company (2015-2020)
    Figure China Cancer Vaccines Sales Value (Million USD) and Growth Rate (2015-2020)
    Table China Cancer Vaccines Sales Value Share of Major Company (2015-2020)
    Table China Cancer Vaccines Price (USD/Unit), by Type (2019-2020)
    Table China Cancer Vaccines Sales (Unit) by Type (2015-2026)
    Figure China Cancer Vaccines Sales (Unit) by Type (2015-2026)
    Table EU Cancer Vaccines Sales (K Unit) of Major Company (2015-2020)
    Table EU Cancer Vaccines Sales Market Share of Major Company (2015-2020)
    Table EU Cancer Vaccines Sales Value (Million USD) of Major Company (2015-2020)
    Figure EU Cancer Vaccines Sales Value (Million USD) and Growth Rate (2015-2020)
    Table EU Cancer Vaccines Sales Value Share of Major Company (2015-2020)
    Table EU Cancer Vaccines Price (USD/Unit), by Type (2019-2020)
    Table EU Cancer Vaccines Sales (Unit) by Type (2015-2026)
    Figure EU Cancer Vaccines Sales (Unit) by Type (2015-2026)
    Table USA Cancer Vaccines Sales (K Unit) of Major Company (2015-2020)
    Table USA Cancer Vaccines Sales Market Share of Major Company (2015-2020)
    Table USA Cancer Vaccines Sales Value (Million USD) of Major Company (2015-2020)
    Figure USA Cancer Vaccines Sales Value (Million USD) and Growth Rate (2015-2020)
    Table USA Cancer Vaccines Sales Value Share of Major Company (2015-2020)
    Table USA Cancer Vaccines Price (USD/Unit), by Type (2019-2020)
    Table USA Cancer Vaccines Sales (Unit) by Type (2015-2026)
    Figure USA Cancer Vaccines Sales (Unit) by Type (2015-2026)
    Table Japan Cancer Vaccines Sales (K Unit) of Major Company (2015-2020)
    Table Japan Cancer Vaccines Sales Market Share of Major Company (2015-2020)
    Table Japan Cancer Vaccines Sales Value (Million USD) of Major Company (2015-2020)
    Figure Japan Cancer Vaccines Sales Value (Million USD) and Growth Rate (2015-2020)
    Table Japan Cancer Vaccines Sales Value Share of Major Company (2015-2020)
    Table Japan Cancer Vaccines Price (USD/Unit), by Type (2019-2020)
    Table Japan Cancer Vaccines Sales (Unit) by Type (2015-2026)
    Figure Japan Cancer Vaccines Sales (Unit) by Type (2015-2026)
    Table India Cancer Vaccines Sales (K Unit) of Major Company (2015-2020)
    Table India Cancer Vaccines Sales Market Share of Major Company (2015-2020)
    Table India Cancer Vaccines Sales Value (Million USD) of Major Company (2015-2020)
    Figure India Cancer Vaccines Sales Value (Million USD) and Growth Rate (2015-2020)
    Table India Cancer Vaccines Sales Value Share of Major Company (2015-2020)
    Table India Cancer Vaccines Price (USD/Unit), by Type (2019-2020)
    Table India Cancer Vaccines Sales (Unit) by Type (2015-2026)
    Figure India Cancer Vaccines Sales (Unit) by Type (2015-2026)
    Table Southeast Asia Cancer Vaccines Sales (K Unit) of Major Company (2015-2020)
    Table Southeast Asia Cancer Vaccines Sales Market Share of Major Company (2015-2020)
    Table Southeast Asia Cancer Vaccines Sales Value (Million USD) of Major Company (2015-2020)
    Figure Southeast Asia Cancer Vaccines Sales Value (Million USD) and Growth Rate (2015-2020)
    Table Southeast Asia Cancer Vaccines Sales Value Share of Major Company (2015-2020)
    Table Southeast Asia Cancer Vaccines Price (USD/Unit), by Type (2019-2020)
    Table Southeast Asia Cancer Vaccines Sales (Unit) by Type (2015-2026)
    Figure Southeast Asia Cancer Vaccines Sales (Unit) by Type (2015-2026)
    Table South America Cancer Vaccines Sales (K Unit) of Major Company (2015-2020)
    Table South America Cancer Vaccines Sales Market Share of Major Company (2015-2020)
    Table South America Cancer Vaccines Sales Value (Million USD) of Major Company (2015-2020)
    Figure South America Cancer Vaccines Sales Value (Million USD) and Growth Rate (2015-2020)
    Table South America Cancer Vaccines Sales Value Share of Major Company (2015-2020)
    Table South America Cancer Vaccines Price (USD/Unit), by Type (2019-2020)
    Table South America Cancer Vaccines Sales (Unit) by Type (2015-2026)
    Figure South America Cancer Vaccines Sales (Unit) by Type (2015-2026)
    Figure Value Chain Structure of Cancer Vaccines
    Table Value Chain
    Table Key Suppliers of Raw Material/Components
    Table Key Downstream Customer in Each Application Field
    Table Industry News List of Cancer Vaccines
    Figure Cost Structure of Cancer Vaccines in 2020
    Table Distributors/Traders List
    Table Regional Market Sales (K Unit) (2021-2026)
    Table Regional Market Sales Share (2021-2026)
    Figure Global Cancer Vaccines Sales (Unit), Growth Rate & Market Share (2021-2026)
    Table Regional Market Sales Value (Million USD) (2021-2026)
    Table Regional Market Sales Value Share (2021-2026)
    Figure Global Cancer Vaccines Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
    Table Dendreon Profiles
    Table Dendreon Cancer Vaccines Product Introduction
    Table Dendreon Cancer Vaccines Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Dendreon SWOT Analysis
    Table GlaxoSmithKline Profiles
    Table GlaxoSmithKline Cancer Vaccines Product Introduction
    Table GlaxoSmithKline Cancer Vaccines Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure GlaxoSmithKline SWOT Analysis
    Table Merck Profiles
    Table Merck Cancer Vaccines Product Introduction
    Table Merck Cancer Vaccines Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Merck SWOT Analysis
    Table Sanofi Profiles
    Table Sanofi Cancer Vaccines Product Introduction
    Table Sanofi Cancer Vaccines Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Sanofi SWOT Analysis
    Table Amgen Profiles
    Table Amgen Cancer Vaccines Product Introduction
    Table Amgen Cancer Vaccines Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Amgen SWOT Analysis
    Table Biothera Profiles
    Table Biothera Cancer Vaccines Product Introduction
    Table Biothera Cancer Vaccines Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Biothera SWOT Analysis
    Table Isa Pharmaceuticals Profiles
    Table Isa Pharmaceuticals Cancer Vaccines Product Introduction
    Table Isa Pharmaceuticals Cancer Vaccines Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Isa Pharmaceuticals SWOT Analysis
    Table Bristol-Myers Squibb Profiles
    Table Bristol-Myers Squibb Cancer Vaccines Product Introduction
    Table Bristol-Myers Squibb Cancer Vaccines Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Bristol-Myers Squibb SWOT Analysis
    Table Bavarian Nordic Profiles
    Table Bavarian Nordic Cancer Vaccines Product Introduction
    Table Bavarian Nordic Cancer Vaccines Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Bavarian Nordic SWOT Analysis
    Table Antigen Express Profiles
    Table Antigen Express Cancer Vaccines Product Introduction
    Table Antigen Express Cancer Vaccines Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Antigen Express SWOT Analysis
    Table Juvaris Biotherapeutics Profiles
    Table Juvaris Biotherapeutics Cancer Vaccines Product Introduction
    Table Juvaris Biotherapeutics Cancer Vaccines Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Juvaris Biotherapeutics SWOT Analysis
    Table Provectus Biopharmaceuticals Profiles
    Table Provectus Biopharmaceuticals Cancer Vaccines Product Introduction
    Table Provectus Biopharmaceuticals Cancer Vaccines Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Provectus Biopharmaceuticals SWOT Analysis
    Table Aduro BioTech Profiles
    Table Aduro BioTech Cancer Vaccines Product Introduction
    Table Aduro BioTech Cancer Vaccines Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Aduro BioTech SWOT Analysis
    Table Galena Biopharma Profiles
    Table Galena Biopharma Cancer Vaccines Product Introduction
    Table Galena Biopharma Cancer Vaccines Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Galena Biopharma SWOT Analysis
    Table Northwest Biotherapeutics Profiles
    Table Northwest Biotherapeutics Cancer Vaccines Product Introduction
    Table Northwest Biotherapeutics Cancer Vaccines Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Northwest Biotherapeutics SWOT Analysis
    Table Oxford BioMedica Profiles
    Table Oxford BioMedica Cancer Vaccines Product Introduction
    Table Oxford BioMedica Cancer Vaccines Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Oxford BioMedica SWOT Analysis
    Table Inovio Pharmaceuticals Profiles
    Table Inovio Pharmaceuticals Cancer Vaccines Product Introduction
    Table Inovio Pharmaceuticals Cancer Vaccines Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Inovio Pharmaceuticals SWOT Analysis
    Table Vaxon Biotech Profiles
    Table Vaxon Biotech Cancer Vaccines Product Introduction
    Table Vaxon Biotech Cancer Vaccines Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Vaxon Biotech SWOT Analysis
    Table Celldex Therapeutics Profiles
    Table Celldex Therapeutics Cancer Vaccines Product Introduction
    Table Celldex Therapeutics Cancer Vaccines Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Celldex Therapeutics SWOT Analysis
    Table Prima BioMed Profiles
    Table Prima BioMed Cancer Vaccines Product Introduction
    Table Prima BioMed Cancer Vaccines Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Post-pandemic Era-Global Cancer Vaccines Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Post-pandemic Era-Global Cancer Vaccines Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Post-pandemic Era-Global Cancer Vaccines Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports